1. Home
  2. WFF vs NRSN Comparison

WFF vs NRSN Comparison

Compare WFF & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WF Holding Limited Ordinary Shares

WFF

WF Holding Limited Ordinary Shares

HOLD

Current Price

$2.41

Market Cap

16.9M

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$6.95

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFF
NRSN
Founded
1984
2017
Country
Malaysia
Israel
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.9M
14.2M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
WFF
NRSN
Price
$2.41
$6.95
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $8.50
AVG Volume (30 Days)
★ 446.2K
338.1K
Earning Date
05-24-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$583.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.25
52 Week High
$10.71
$7.50

Technical Indicators

Market Signals
Indicator
WFF
NRSN
Relative Strength Index (RSI) 62.61 79.64
Support Level $1.78 $0.63
Resistance Level $2.47 $7.50
Average True Range (ATR) 0.24 0.63
MACD 0.04 0.36
Stochastic Oscillator 57.34 92.33

Price Performance

Historical Comparison
WFF
NRSN

About WFF WF Holding Limited Ordinary Shares

WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings, and other custom-made FRP products. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance. Geographically, the company generates the majority of its revenue from Australia.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: